This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Stroke  • Alert me on articles by topic

edited by Scott E. Kasner, MD, and Phillip B. Gorelick, MD, 416 pp, ISBN 0750674644, Philadelphia, Pa, Butterworth-Heinemann, 2004.

Arch Neurol. 2004;61:1805-1806.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The past 2 decades have witnessed a veritable revolution in information about stroke. The available technology to quickly and safely evaluate patients with cardiovascular and cerebrovascular diseases has improved dramatically. Formerly, therapeutic nihilism reigned supreme, and most physicians believed that little could be done to prevent or treat stroke. Now stroke therapeutics has also changed dramatically, boosted substantially in 1996 with the approval of intravenous recombinant tissue-type plasminogen activator to treat patients with acute ischemic stroke. Unfortunately, few neurologists and even fewer general physicians, internists, and emergency physicians have been able to keep up-to-date with the knowledge they need to treat and prevent strokes. This book aims at the large information gap.

The editors wisely decided to limit the subject matter to brain ischemia. The coverage of this topic is generally very thorough and current. Most chapters are heavily referenced, and the references are recent. Chapters are authored by established . . . [Full Text of this Article]

AUTHOR INFORMATION

Louis R. Caplan, MD, Reviewer